Global Vascular Closure Devices Industry

Reduction in Interventional Cardiology Treatment Means Patients Are Not Receiving Timely Care. Vascular Closure Devices Slumps by -3. 9% On the Back of Declining Procedures. The global market for Vascular Closure Devices is projected to decline by over -3.

New York, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vascular Closure Devices Industry" - https://www.reportlinker.com/p05896474/?utm_source=GNW
9% in the year 2020 and thereafter recover and grow to reach US$1.1 billion by the year 2027, trailing a post COVID-19 CAGR of 6.8% over the analysis period 2020 through 2027. A vascular closure device is a medical device designed to provide rapid hemostasis and reduce vascular complications after percutaneous femoral access and. Vascular closure devices also improve patient comfort, reduce discomfort associated with prolonged bed rest, facilitate early patient mobilization, and decrease hospital length of stay. These devices have emerged as an effective alternative to traditional mechanical compression for femoral artery closure. Suture-based and metal clip-based vascular closure devices reduce time to hemostasis when compared with manual or mechanical compression. Vascular closure devices are being widely used in patients undergoing cardiac catheterization through femoral arterial access. Cardiovascular procedures that require catheterization include interventional procedures such as angioplasty, coronary thrombectomy and placement of a stent, and diagnostic procedures that help diagnose diseased blood vessels. Vascular closure devices are particularly useful for large patients not suitable for manual compression, patients on blood thinning medications such as heparin or warfarin, and sicker or geriatric patients unable to lie flat after angiographic procedure for several hours.

The market in the current year 2020 is hurting from the disruptions and excessive pressure exerted on healthcare systems by the COVID-19 pandemic. Six months into the pandemic, this unprecedented public healthcare crisis continues to evolve and shows no signs of receding. The pandemic has impacted all areas of healthcare provision, including cardiovascular (CVD) care and has necessitated the prioritization of healthcare infrastructure for COVID-19 patients, affecting other patients across the world. With all elective surgeries cancelled and postponed there has been a significant drop in angiogram diagnostic test procedures and other cardiac surgeries. Several factors have affected delivery of timely CVD care including social distancing norms; reallocation of staff in cardiology department to covid-19 care; cancelation of cardiac imaging; cancelation of elective procedures; closure of outpatient clinics; shortage of P.P.E; hospital initiated postponement of scheduled angiograms; increased fear & anxiety among patients over safety in hospital settings; delayed diagnosis of acute coronary syndrome; deterioration of cardiac health of patients; late admission of patients to hospitals with acute precipitated cardiac emergencies; overwhelmed healthcare staff & facilities. All of these factors are reducing patient throughput in cardiology centers worldwide thereby reducing demand for cardiac care equipment including vascular closure devices.

In the post COVID-19 period as the world learns to live with the virus and healthcare services resume, the market will witness a return to growth. The postponements in screenings and delays in diagnosis and treatments will create pent-up demand for cardiac care services. The year 2021 is expected to witness steady growth in CVD surgeries requiring femoral artery cardiac catheterization. Increasing burden of CVD will continue to spur growth in the market over the medium to long-term period. CVD is one of the major causes of deaths worldwide. By 2030, the number of deaths due to CVDs is forecast to reach 24 million. The significant rise in the number of cardiac interventional procedures therefore is anticipated to create strong demand growth scenario for VCDs over the coming years. Increasing use of imaging technologies for monitoring cardiac functions and radiotherapy will also create market growth opportunities as they lead to increase heart surgeries performed. With the rise in the number of interventional procedures needing larger devices, there will be increased demand for larger-bore vascular access arteriotomies. Devices utilized for endovascular aneurysm repair (EVAR), transcatheter aortic valve implantation (TAVI), balloon aortic valvuloplasty (BAV), and percutaneous ventricular assist device (VAD) implantation require larger access, making it hard to close using traditional methods. Large-bore femoral access sites have been linked with morbidity, including higher times to obtain hemostasis, longer procedure time, delayed ambulation, higher costs and complication rates. Faster hemostasis reduces bleeding complications, saves nursing time after the procedure, increases patient throughput, quickens patient ambulation, and increases overall patient satisfaction. Further, it supports hospitals following percutaneous coronary intervention (PCI) programs. In November 2018, Vivasure Medical Ltd. launched the large-bore PerQseal closure device in European region. During the same year, Cardiva Medical Inc. received premarhet approval (PMA) for Vascade MVP venous vascular closure system from the US FDA. Vascade MVP is labelled and designed to assist in multi-site venous closures for French sized 6-12 inner diameter sheaths.

Competitors identified in this market include, among others,

• Abbott Laboratories, Inc.

• Cardinal Health, Inc.

• Cardiva Medical, Inc.

• Essential Medical, Inc.

• Inseal Medical Ltd.

• Medtronic PLC

• Merit Medical Systems, Inc.

• Terumo Corporation

• Tricol Biomedical, Inc.

• Tz Medical, Inc.

• Vasorum Ltd.

• Vivasure Medical Ltd.

Read the full report: https://www.reportlinker.com/p05896474/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE I-1

II. EXECUTIVE SUMMARY II-1

1. MARKET OVERVIEW II-1
Vascular Closure Devices - A Prelude II-1
Benefits II-1
Active Approximators II-1
Passive Approximators II-2
External Hemostatic Devices II-4
Vascular Closure Devices to Witness Steady Growth Post COVID-19 II-4
Interventional Cardiology to Dominate the Market II-5
Passive Approximators Lead the Market II-5
Femoral Access Type Leads the Market II-6
United States Holds a Dominant Share, Asia-Pacific to Witness
Rapid Growth II-6
Competition II-7
Growth Restraints II-7
World Brands II-7

2. FOCUS ON SELECT PLAYERS II-8
Recent Market Activity II-9

3. MARKET TRENDS & DRIVERS II-10
Medical Device Companies Focus on Developing Advanced
Biomechanical VCDs II-10
Increasing Demand for Large-bore Vascular Closure Devices II-10
Select Large Bore Closure Devices II-11
Cardiovascular Diseases: A Significant Contributor to Market
Growth II-12
Exhibit 1: Fatalities by Heart Conditions: Estimated Percentage
Breakdown for Cardiovascular Disease, Ischemic Heart Disease,
Stroke, and Others II-13
Exhibit 2: Global Annual Medical Cost of CVD in US$ Billion (
2010-2030) II-13
Rising Preference for Minimally Invasive Procedures Boosts
Market Prospects II-14
Aging Population Drives Demand for Vascular Closure Devices II-15
Exhibit 3: Expanding Elderly Population Worldwide: Breakdown of
Number of People Aged 65+ Years in Million by Geographic
Region for the Years 2019 and 2030 II-15
Exhibit 4: Life Expectancy for Select Countries in Number of
Years: 2019 II-16
Increasing Healthcare Expenditure to Foster Growth II-16
Exhibit 5: World Healthcare Expenditure (In US$ Trillion) for
the Years 2016 & 2018 II-17
Recent Approvals and Launches II-18
Essential Medical Inc Receives FDA Clearance for its Large-Bore
Vascular Closure Device II-18
Vascade MVP Vascular Closure System Obtains Approval from FDA II-18
Large Bore PerQseal Closure Device Introduced in Europe II-18
Cordis Introduces Mynx Control Vascular Closure Device II-18
FDA Approves Teleflex?s Vascular Closure Device II-18
Vasorum Set to Commercialize a New Vascular Closure Device
across the US II-19

4. GLOBAL MARKET PERSPECTIVE II-20
Table 1: World Current & Future Analysis for Vascular Closure
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-20

Table 2: World Historic Review for Vascular Closure Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-21

Table 3: World 15-Year Perspective for Vascular Closure Devices
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027 II-22

Table 4: World Current & Future Analysis for Passive
Approximators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-23

Table 5: World Historic Review for Passive Approximators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-24

Table 6: World 15-Year Perspective for Passive Approximators by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-25

Table 7: World Current & Future Analysis for Active
Approximators by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-26

Table 8: World Historic Review for Active Approximators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-27

Table 9: World 15-Year Perspective for Active Approximators by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-28

Table 10: World Current & Future Analysis for External
Hemostatic Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 II-29

Table 11: World Historic Review for External Hemostatic Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-30

Table 12: World 15-Year Perspective for External Hemostatic
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027 II-31

Table 13: World Current & Future Analysis for Interventional
Cardiology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-32

Table 14: World Historic Review for Interventional Cardiology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-33

Table 15: World 15-Year Perspective for Interventional
Cardiology by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027 II-34

Table 16: World Current & Future Analysis for Interventional
Radiology/Vascular Surgery by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 II-35

Table 17: World Historic Review for Interventional
Radiology/Vascular Surgery by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 II-36

Table 18: World 15-Year Perspective for Interventional
Radiology/Vascular Surgery by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027 II-37

Table 19: World Current & Future Analysis for Femoral by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-38

Table 20: World Historic Review for Femoral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 II-39

Table 21: World 15-Year Perspective for Femoral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027 II-40

Table 22: World Current & Future Analysis for Radial by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-41

Table 23: World Historic Review for Radial by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 II-42

Table 24: World 15-Year Perspective for Radial by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027 II-43

III. MARKET ANALYSIS III-1

GEOGRAPHIC MARKET ANALYSIS III-1

UNITED STATES III-1
Table 25: USA Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027 III-1

Table 26: USA Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 III-2

Table 27: USA 15-Year Perspective for Vascular Closure Devices
by Type - Percentage Breakdown of Value Sales for Passive
Approximators, Active Approximators and External Hemostatic
Devices for the Years 2012, 2020 & 2027 III-3

Table 28: USA Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-4

Table 29: USA Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-5

Table 30: USA 15-Year Perspective for Vascular Closure Devices
by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027 III-6

Table 31: USA Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-7

Table 32: USA Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-8

Table 33: USA 15-Year Perspective for Vascular Closure Devices
by Access - Percentage Breakdown of Value Sales for Femoral and
Radial for the Years 2012, 2020 & 2027 III-9

CANADA III-10
Table 34: Canada Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027 III-10

Table 35: Canada Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-11

Table 36: Canada 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027 III-12

Table 37: Canada Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-13

Table 38: Canada Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-14

Table 39: Canada 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027 III-15

Table 40: Canada Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-16

Table 41: Canada Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 III-17

Table 42: Canada 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027 III-18

JAPAN III-19
Graying Population Spurs Growth of Vascular Closure Devices III-19
Exhibit 6: Japanese Population by Age Group (2015 & 2040):
Percentage Share Breakdown of Population for 0-14, 15-64 and
65 & Above Age Groups III-19
Market Analytics III-20
Table 43: Japan Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027 III-20

Table 44: Japan Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 III-21

Table 45: Japan 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027 III-22

Table 46: Japan Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-23

Table 47: Japan Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-24

Table 48: Japan 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027 III-25

Table 49: Japan Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-26

Table 50: Japan Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-27

Table 51: Japan 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027 III-28

CHINA III-29
Table 52: China Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027 III-29

Table 53: China Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 III-30

Table 54: China 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027 III-31

Table 55: China Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-32

Table 56: China Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-33

Table 57: China 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027 III-34

Table 58: China Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-35

Table 59: China Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-36

Table 60: China 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027 III-37

EUROPE III-38
Ageing Demography - An Opportunity Indicator III-38
Exhibit 7: European Population by Age Group (2016, 2030 & 2050):
Percentage Share Breakdown by Age Group for 0-14, 15-64,
and 65 & Above III-38
Market Analytics III-39
Table 61: Europe Current & Future Analysis for Vascular Closure
Devices by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 III-39

Table 62: Europe Historic Review for Vascular Closure Devices
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-40

Table 63: Europe 15-Year Perspective for Vascular Closure
Devices by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027 III-41

Table 64: Europe Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027 III-42

Table 65: Europe Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-43

Table 66: Europe 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027 III-44

Table 67: Europe Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-45

Table 68: Europe Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-46

Table 69: Europe 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027 III-47

Table 70: Europe Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-48

Table 71: Europe Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 III-49

Table 72: Europe 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027 III-50

FRANCE III-51
Table 73: France Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027 III-51

Table 74: France Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-52

Table 75: France 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027 III-53

Table 76: France Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-54

Table 77: France Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-55

Table 78: France 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027 III-56

Table 79: France Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-57

Table 80: France Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 III-58

Table 81: France 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027 III-59

GERMANY III-60
Table 82: Germany Current & Future Analysis for Vascular
Closure Devices by Type - Passive Approximators, Active
Approximators and External Hemostatic Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-60

Table 83: Germany Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-61

Table 84: Germany 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027 III-62

Table 85: Germany Current & Future Analysis for Vascular
Closure Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-63

Table 86: Germany Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-64

Table 87: Germany 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027 III-65

Table 88: Germany Current & Future Analysis for Vascular
Closure Devices by Access - Femoral and Radial - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-66

Table 89: Germany Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 III-67

Table 90: Germany 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027 III-68

ITALY III-69
Table 91: Italy Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027 III-69

Table 92: Italy Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 III-70

Table 93: Italy 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2020 & 2027 III-71

Table 94: Italy Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and
Interventional Radiology/Vascular Surgery - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-72

Table 95: Italy Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-73

Table 96: Italy 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2020 & 2027 III-74

Table 97: Italy Current & Future Analysis for Vascular Closure
Devices by Access - Femoral and Radial - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-75

Table 98: Italy Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 III-76

Table 99: Italy 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2020 & 2027 III-77

UNITED KINGDOM III-78
Table 100: UK Current & Future Analysis for Vascular Closure
Devices by Type - Passive Approximators, Active Approximators
and External Hemostatic Devices - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027 III-78

Table 101: UK Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 III-79

Table 102: UK 15-Year Perspective for Vascular Closure Devices
by Type - Percentage Breakdown of Value Sales for Passive
Approximators, Active Approximators and External Hemostatic
Devices for the Years 2012, 2020 & 2027 III-80

Table 103: UK Current & Future Analysis for Vascular Closure
Devices by Procedure - Interventional Cardiology and

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05896474/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001